跳至主要内容
临床试验/CTRI/2018/01/011154
CTRI/2018/01/011154尚未招募3 期

Role of Asvagandhadi Capsules in the management of Madhumehajanya upadrava W.S.R.to Diabetic polyneuropathy-An open label randomized controlled clinical trial.

IPGT and RA through Department of AYUSH Government of India0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Fasting plasma glucose >= 126 mg/dl or PostPrandial glucose level >= 200 mg/dl
  • 2 Metabolically stable Type 2 Diabetics with symptomatic diabetic Sensorimotor Polyneuropathy

排除标准

  • 1 Age less than 18 years and more than 70 years
  • 2 Patients with complications- Diabetic Nephropathy Diabetic Keto acidosis & Diabetic coma
  • 3 Patients with uncontrolled diabetes
  • 4 Patients with other metabolic & endocrine disorders
  • 5 Patients suffering from HIV TB
  • 6 Patients having any other malignancies any other serious illnesses

研究者

发起方
IPGT and RA through Department of AYUSH Government of India

相似试验